New publication from independent research validates Dr. Goodenowe’s original hypothesis on plasmalogens and Alzheimer’s.
New research published from a study of 1,112 individuals in Australia further confirms that plasmalogen molecules are low in persons with Alzheimer’s disease. The authors found that low plasmalogens are associated with all risk factors of Alzheimer’s disease and with the disease itself. This independent, peer-reviewed research supports Dr. Goodenowe’s original hypothesis from his landmark 2007 paper titled “Peripheral Ethanolamine Plasmalogen Deficiency – A Logical Causative Factor in Alzheimer’s Disease and Dementia”.
Prodrome Sciences offers blood testing to measure plasmalogen levels and natural plasmalogen supplements, ProdromeNeuro and ProdromeGlia, for the safe and effective restoration of these critical molecules.
Contact us for more information.